Skip to content
PIL Logo

Dalacin C Capsules 75mg

Last Updated on eMC 03-May-2017 View document  | Pfizer Limited Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 03-May-2017 and displayed until Current

Reasons for adding or updating:

  • Change to section 3 - use in children/adolescents
  • Change to section 3 - overdose, missed or forgotten doses
  • Change to section 4 - possible side effects
  • Change to section 5 - how to store or dispose
  • Change to section 6 - date of revision
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - use in children/adolescents
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 2 - pregnancy, breast feeding and fertility
  • Change to section 2 - excipient warnings

Updated on 02-Oct-2014 and displayed until 03-May-2017

Reasons for adding or updating:

  • Change to section 6 - manufacturer
  • Change to section 6 - date of revision

Updated on 30-Jun-2014 and displayed until 02-Oct-2014

Reasons for adding or updating:

  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision

Updated on 16-Aug-2013 and displayed until 30-Jun-2014

Reasons for adding or updating:

  • Change to section 6 - marketing authorisation holder
  • Change to section 6 - marketing authorisation number
  • Change to section 6 - date of revision

Updated on 06-Oct-2011 and displayed until 16-Aug-2013

Reasons for adding or updating:

  • Correction of spelling/typing errors

Updated on 22-May-2008 and displayed until 06-Oct-2011

Reasons for adding or updating:

  • Change due to user-testing of patient information

Updated on 05-Sep-2007 and displayed until 22-May-2008

Reasons for adding or updating:

  • Change to date of revision
  • Change to MA holder contact details

Updated on 31-May-2007 and displayed until 05-Sep-2007

Reasons for adding or updating:

  • Change to warnings or special precautions for use
  • Change to side-effects

Updated on 03-Apr-2006 and displayed until 31-May-2007

Reasons for adding or updating:

  • Change of manufacturer

Updated on 26-Oct-2004 and displayed until 03-Apr-2006

Reasons for adding or updating:

  • Change to side-effects

Updated on 12-Jun-2003 and displayed until 26-Oct-2004

Reasons for adding or updating:

  • Update to PIL

Updated on 28-Dec-2001 and displayed until 12-Jun-2003

Reasons for adding or updating:

  • Update to PIL

Updated on 10-Aug-2000 and displayed until 28-Dec-2001

Reasons for adding or updating:

  • No reasons supplied

Company contact details

Pfizer Limited

Company image
Address

Ramsgate Road, Sandwich, Kent, CT13 9NJ

Fax

+44 (0)1304 656 221

Telephone

+44 (0)1304 616 161

Medical Information Website

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

clindamycin hydrochloride

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue